Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The healthcare sector has been making headlines recently, with many calling for regulatory and systemic reforms
as insurance premiums are expected to rise by up to 70% next year. As a result, the Health Ministry has proposed that diagnosis-related group pricing system, (DRG) be implemented. Oong Chun Sung, Equity Research Analyst, RHB Investment Bank tells us if DRG will be a boom or bane for earnings and which listed companies stand to benefit.
Image Credits: Shutterstock.com
See omnystudio.com/listener for privacy information.